EyeMed Technologies
Premium Lens for Intraocular Implantation
Company Overview
Snapshot
Founded in April 2018 by Nir Shimoni and Vadim Shmukler, EyeMed Technologies operates with 1–10 employees. The company has raised $5.8M across three funding rounds. In November 2023, the company closed a Series A funding round.
Business overview
EyeMed Technologies is a Health Tech & Life Sciences company focused on developing adjustable intraocular lenses (IOLs) to address issues with effective lens position (ELP) prediction and IOL positioning errors. Its core product, VaLens, is a foldable, injectable, and post-operative adjustable IOL designed to allow cataract surgeons to precisely optimize lens position and power non-invasively after surgery. The company operates within the medical devices, medical treatment, and therapeutics sectors, serving the healthcare and medical devices industries.
Strategic signal
In November 2023, EyeMed Technologies successfully closed a Series A funding round. This milestone indicates strong investor confidence in the company's innovative VaLens technology and its potential to significantly improve outcomes in cataract surgery by enabling post-operative, non-invasive lens adjustments. This capital infusion is crucial for advancing the development and commercialization of their adjustable IOL, positioning EyeMed Technologies for further growth in the ophthalmology market.
Log in to access full profile ›Company Intelligence Q&A
- What is EyeMed Technologies' primary product?
- EyeMed Technologies is developing VaLens, an intraocular lens (IOL) designed to allow cataract surgeons to precisely adjust the lens's position and power non-invasively after cataract surgery.
- When was EyeMed Technologies founded?
- EyeMed Technologies was founded in April 2018.
- Who are the founders of EyeMed Technologies?
- Nir Shimoni and Vadim Shmukler are the co-founders of EyeMed Technologies.
- What is the total capital raised by EyeMed Technologies?
- EyeMed Technologies has raised a total of $5.8M across three funding rounds.
- When did EyeMed Technologies close its Series A funding round?
- EyeMed Technologies closed its Series A funding round in November 2023, with MEDX Xelerator as an investor.